Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model
Gastroschisis (GS) is an abdominal wall defect that results in histological and morphological changes leading to intestinal motility perturbation and impaired absorption of nutrients. Due to its anti-inflammatory, antioxidant, and neuroprotective effects, cannabidiol (CBD) has been used as a therapeutic agent in many diseases. Our aim was to test the effect of maternal CBD in the intestine of an experimental model of GS. Pregnant rats were treated over 3 days with CBD (30 mg/kg) after the surgical induction of GS (day 18.5 of gestation) and compared to controls. Fetuses were divided into 4 groups: 1) control (C); 2) C+CBD (CCBD); 3) gastroschisis (G), and 4) G+CBD (GCBD). On day 21.5 of gestation, the fetuses were harvested and evaluated for: a) body weight (BW), intestinal weight (IW), and IW/BW ratio; b) histometric analysis of the intestinal wall; c) immunohistochemically analysis of inflammation (iNOS) and nitrite/nitrate level. BW: GCBD was lower than CCBD (P<0.005), IW and IW/BW ratio: GCBD was smaller than G (P<0.005), GCBD presented lower thickness in all parameters compared to G (P<0.005), iNOS and nitrite/nitrate were lower concentration in GCBD than to G (P<0.005). Maternal use of CBD had a beneficial effect on the intestinal loops of GS with decreased nitrite/nitrate and iNOS expression.
Main Authors: | Callejas,G.H., Figueira,R.L., Gonçalves,F.L.L., Volpe,F.A.P., Zuardi,A.W., Crippa,J.A., Hallak,J.E., Sbragia,L. |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2018
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000500607 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory response in a rat model of gastroschisis is associated with an increase of NF-kappaB
by: Sbragia,L., et al.
Published: (2010) -
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
by: Zuardi,A.W., et al.
Published: (2006) -
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
by: Meneses-Gaya,Carolina de, et al.
Published: (2021) -
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
by: Schier,Alexandre Rafael de Mello, et al.
Published: (2012) -
Biological bases for a possible effect of cannabidiol in Parkinson’s disease
by: Ferreira-Junior,Nilson C., et al.
Published: (2020)